Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Pain. 2020 May;161(5):1037–1043. doi: 10.1097/j.pain.0000000000001791

Fig 3.

Fig 3.

A. Examples of CSD traces that show different spreading velocities among saline-, isotype- and fremanezumab-treated groups. B. Box plots (median and IQR) showing differences in the CSD spreading velocity between the saline-, isotype- and fremanezumab-treated groups. Note that the propagation velocity was slower in the isotype- and fremanezumab-treated animals, and that there was no significant difference between the fremanezumab- and isotype-treated groups (p>0.05).